Latest & greatest articles for tuberculosis

The Trip Database is a leading resource to help health professionals find trustworthy answers to their clinical questions. Users can access the latest research evidence and guidance to answer their clinical questions. We have a large collection of systematic reviews, clinical guidelines, regulatory guidance, clinical trials and many other forms of evidence. If you wanted the latest trusted evidence on tuberculosis or other clinical topics then use Trip today.

This page lists the very latest high quality evidence on tuberculosis and also the most popular articles. Popularity measured by the number of times the articles have been clicked on by fellow users in the last twelve months.

What is Trip?

Trip is a clinical search engine designed to allow users to quickly and easily find and use high-quality research evidence to support their practice and/or care.

Trip has been online since 1997 and in that time has developed into the internet’s premier source of evidence-based content. Our motto is ‘Find evidence fast’ and this is something we aim to deliver for every single search.

As well as research evidence we also allow clinicians to search across other content types including images, videos, patient information leaflets, educational courses and news.

For further information on Trip click on any of the questions/sections on the left-hand side of this page. But if you still have questions please contact us via jon.brassey@tripdatabase.com

Top results for tuberculosis

181. Providers' knowledge of diagnosis and treatment of tuberculosis using vignettes: evidence from rural Bihar, India (Full text)

Providers' knowledge of diagnosis and treatment of tuberculosis using vignettes: evidence from rural Bihar, India Almost 25% of all new cases of tuberculosis (TB) worldwide are in India, where drug resistance and low quality of care remain key challenges.We conducted an observational, cross-sectional study of healthcare providers' knowledge of diagnosis and treatment of TB in rural Bihar, India, from June to September 2012. Using data from vignette-based interviews with 395 most commonly

2016 BMJ global health PubMed

182. Potential impact of spatially targeted adult tuberculosis vaccine in Gujarat, India. (Full text)

Potential impact of spatially targeted adult tuberculosis vaccine in Gujarat, India. Some of the most promising vaccines in the pipeline for tuberculosis (TB) target adolescents and adults. Unlike for childhood vaccines, high-coverage population-wide vaccination is significantly more challenging for adult vaccines. Here, we aimed to estimate the impact of vaccine delivery strategies that were targeted to high-incidence geographical 'hotspots' compared with randomly allocated vaccination. We

2016 Journal of the Royal Society, Interface PubMed

183. Peritoneal tuberculosis with elevated CA-125 mimicking ovarian cancer with carcinomatosis peritonei: Crucial CT findings (Full text)

Peritoneal tuberculosis with elevated CA-125 mimicking ovarian cancer with carcinomatosis peritonei: Crucial CT findings Preoperative diagnosis of peritoneal tuberculosis is often difficult because of confusion with ovarian cancer. A 56-year-old woman was admitted to our hospital with abdominal fullness. Ascites, prominent bilateral ovaries, and elevated CA-125 were noted. Computed tomography showed thickened peritoneum and strandings in the mesentery and omentum. Exploratory laparotomy (...) was performed under the provisional diagnosis of ovarian cancer, but the final diagnosis was peritoneal tuberculosis. Careful evaluation of bilateral fallopian tubes and ovaries and peritoneum are helpful for correct diagnosis.

2016 EXCLI journal PubMed

184. Six-month therapy for abdominal tuberculosis. (Full text)

Six-month therapy for abdominal tuberculosis. Tuberculosis (TB) of the gastrointestinal tract and any other organ within the abdominal cavity is abdominal TB, and most guidelines recommend the same six-month regimen used for pulmonary TB for people with this diagnosis. However, some physicians are concerned whether a six-month treatment regimen is long enough to prevent relapse of the disease, particularly in people with gastrointestinal TB, which may sometimes cause antituberculous drugs

2016 Cochrane PubMed

185. Diabetes Mellitus as Hub for Tuberculosis Infection: A Snapshot (Full text)

Diabetes Mellitus as Hub for Tuberculosis Infection: A Snapshot Tuberculosis (TB) still remains the thorn in the flesh of efficient therapeutics affecting one-third of global population annually. There are several factors that enhance the susceptibility to TB infections including malnutrition, smoking, and immunocompromised conditions such as AIDS. In the recent years, growing body of evidence has gained considerable prominence which suggests that Diabetes Mellitus (DM) is individual risk

2016 International journal of chronic diseases PubMed

186. Tuberculosis in migrants moving from high-incidence to low-incidence countries: a population-based cohort study of 519 955 migrants screened before entry to England, Wales, and Northern Ireland. (Full text)

Tuberculosis in migrants moving from high-incidence to low-incidence countries: a population-based cohort study of 519 955 migrants screened before entry to England, Wales, and Northern Ireland. Tuberculosis elimination in countries with a low incidence of the disease necessitates multiple interventions, including innovations in migrant screening. We examined a cohort of migrants screened for tuberculosis before entry to England, Wales, and Northern Ireland and tracked the development (...) of disease in this group after arrival.As part of a pilot pre-entry screening programme for tuberculosis in 15 countries with a high incidence of the disease, the International Organization for Migration screened all applicants for UK visas aged 11 years or older who intended to stay for more than 6 months. Applicants underwent a chest radiograph, and any with results suggestive of tuberculosis underwent sputum testing and culture testing (when available). We tracked the development of tuberculosis

2016 Lancet PubMed

187. Psychosocial wellbeing of patients with multidrug resistant tuberculosis voluntarily confined to long-term hospitalisation in Nigeria (Full text)

Psychosocial wellbeing of patients with multidrug resistant tuberculosis voluntarily confined to long-term hospitalisation in Nigeria Patient isolation, which is a widely successful treatment strategy for tuberculosis (TB), has been suspected to have effects on patient psychosocial wellbeing. We assessed the psychosocial wellbeing of multidrug resistant TB (MDR-TB) patients in voluntary and isolated long-term hospitalisation in Nigeria.98 accessible and consenting patients in four drug

2016 BMJ global health PubMed

188. Identification of populations at high risk of tuberculosis infection in rural China: a population-based, multicentre, prospective study. (Full text)

Identification of populations at high risk of tuberculosis infection in rural China: a population-based, multicentre, prospective study.

2016 Lancet PubMed

189. Occupational challenges of physicians involved in tuberculosis control in China: a qualitative study. (PubMed)

Occupational challenges of physicians involved in tuberculosis control in China: a qualitative study.

2016 Lancet

190. Cost-effectiveness of triage testing for facility-based systematic screening of tuberculosis among Ugandan adults (Full text)

Cost-effectiveness of triage testing for facility-based systematic screening of tuberculosis among Ugandan adults Systematic screening is often proposed as a way to improve case finding for tuberculosis (TB), but the cost-effectiveness of specific strategies for systematic screening remains poorly studied.We constructed a Markov-based decision analytic model to analyse the cost-effectiveness of triage testing for TB in Uganda, compared against passive case detection with Xpert MTB/RIF. We

2016 BMJ global health PubMed

191. Hematological and liver toxicity of anti-tuberculosis drugs (Full text)

Hematological and liver toxicity of anti-tuberculosis drugs Tuberculosis (TB) is a major global health problem, and anti-tuberculosis drugs can cause severe adverse reactions. The aim of this study was to determine hematological and biochemical changes and associated risk factors in smear positive pulmonary tuberculosis patients undergoing treatment with standard protocols.In a descriptive study, a total of 40 tuberculosis patients aged between 15-60 years were collected from hospitals (...) , HCT, MCV, MCH, and MCHC), except platelet count, were changed significantly (p ≤ 0.001). Liver enzyme activities (ALT, AST, and ALP) were decreased significantly (p ≤ 0.001) after treatment.In this study, changes of hematological and biochemical parameters have been observed in patients with pulmonary tuberculosis. It can be concluded that the anti-tuberculosis treatment is associated with changes of hematological parameters and liver enzymes.

2016 Electronic physician PubMed

192. GenoType<sup>®</sup> MTBDRsl assay for resistance to second-line anti-tuberculosis drugs. (Full text)

GenoType® MTBDRsl assay for resistance to second-line anti-tuberculosis drugs. Genotype® MTBDRsl (MTBDRsl) is a rapid DNA-based test for detecting specific mutations associated with resistance to fluoroquinolones and second-line injectable drugs (SLIDs) in Mycobacterium tuberculosis complex. MTBDRsl version 2.0 (released in 2015) identifies the mutations detected by version 1.0, as well as additional mutations. The test may be performed on a culture isolate or a patient specimen (...) , which eliminates delays associated with culture. Version 1.0 requires a smear-positive specimen, while version 2.0 may use a smear-positive or -negative specimen. We performed this updated review as part of a World Health Organization process to develop updated guidelines for using MTBDRsl.To assess and compare the diagnostic accuracy of MTBDRsl for: 1. fluoroquinolone resistance, 2. SLID resistance, and 3. extensively drug-resistant tuberculosis, indirectly on a M. tuberculosis isolate grown from

2016 Cochrane PubMed

193. Primary Care Screening and Treatment for Latent Tuberculosis Infection in Adults: Evidence Report and Systematic Review for the US Preventive Services Task Force. (Full text)

Primary Care Screening and Treatment for Latent Tuberculosis Infection in Adults: Evidence Report and Systematic Review for the US Preventive Services Task Force. Five to ten percent of individuals with latent tuberculosis infection (LTBI) progress to active tuberculosis (TB) disease. Identifying and treating LTBI is a key component of the strategy for reducing the burden of TB disease.To review the evidence about targeted screening and treatment for LTBI among adults in primary care settings

2016 JAMA PubMed

194. Screening for Latent Tuberculosis Infection in Adults: US Preventive Services Task Force Recommendation Statement. (Full text)

Screening for Latent Tuberculosis Infection in Adults: US Preventive Services Task Force Recommendation Statement. Tuberculosis remains an important preventable disease in the United States. An effective strategy for reducing the transmission, morbidity, and mortality of active disease is the identification and treatment of latent tuberculosis infection (LTBI) to prevent progression to active disease.To issue a current US Preventive Services Task Force (USPSTF) recommendation on screening

2016 JAMA PubMed

195. Chronic heel pain: It could be tuberculosis (Full text)

Chronic heel pain: It could be tuberculosis Heel pain is a common presentation at a primary care setting. The majority of these cases are benign and self limiting in nature. Common differential diagnoses include plantar fasciitis and peroneal muscle sprains. However, certain conditions-if undetected early-may cause significant morbidity to the patient. A high index of suspicion and early referral for further investigations are needed to prevent long-term morbidities.A clinical review (...) of a patient with chronic left heel pain was performed. Blood parameters and imaging investigations indicated chronic infection of the calcaneum. Histopathological examination was highly suggestive of tuberculosis.The patient responded well to antituberculous therapy. She was pain free and showed no signs of recurrence at final follow-up.Here, we report a case of chronic heel pain, which was later diagnosed as tuberculosis of the calcaneum and successfully treated with antituberculous therapy.

2016 Malaysian family physician : the official journal of the Academy of Family Physicians of Malaysia PubMed

196. Head and neck tuberculosis: The great mimic (Full text)

Head and neck tuberculosis: The great mimic 28461859 2018 11 13 1985-207X 11 2-3 2016 Malaysian family physician : the official journal of the Academy of Family Physicians of Malaysia Malays Fam Physician Head and neck tuberculosis: The great mimic. 38 Mohamad I I MD, M.Med (ORL-HNS), School of Medical Sciences, Universiti Sains Malaysia Health Campus, Kelantan, Malaysia, email:irfankb@usm.my. Nik Hassan Nfh N MD, M.Med (ORL-HNS), School of Health Sciences, Universiti Sains Malaysia Health (...) Campus, Kelantan, Malaysia. Nik Othman N A NA MBChB, M.Med (ORL-HNS), School of Health Sciences, Universiti Sains Malaysia Health Campus, Kelantan, Malaysia. eng Journal Article 2016 08 31 Malaysia Malays Fam Physician 101466855 1985-2274 Otolaryngology Tuberculosis Tuberculosis vaccines 2017 5 3 6 0 2017 5 4 6 0 2017 5 4 6 1 epublish 28461859 PMC5408878 J Laryngol Otol. 2009 Jul;123(7):764-7 18845038 Hum Vaccin Immunother. 2013 Aug;9(8):1763-73 23584253 Acta Med Indones. 2006 Jan-Mar;38(1):29-32

2016 Malaysian family physician : the official journal of the Academy of Family Physicians of Malaysia PubMed

197. HIV and tuberculosis in prisons in sub-Saharan Africa. (Full text)

HIV and tuberculosis in prisons in sub-Saharan Africa. Given the dual epidemics of HIV and tuberculosis in sub-Saharan Africa and evidence suggesting a disproportionate burden of these diseases among detainees in the region, we aimed to investigate the epidemiology of HIV and tuberculosis in prison populations, describe services available and challenges to service delivery, and identify priority areas for programmatically relevant research in sub-Saharan African prisons. To this end, we (...) reviewed literature on HIV and tuberculosis in sub-Saharan African prisons published between 2011 and 2015, and identified data from only 24 of the 49 countries in the region. Where data were available, they were frequently of poor quality and rarely nationally representative. Prevalence of HIV infection ranged from 2·3% to 34·9%, and of tuberculosis from 0·4 to 16·3%; detainees nearly always had a higher prevalence of both diseases than did the non-incarcerated population in the same country. We

2016 Lancet PubMed

198. Clinical care of incarcerated people with HIV, viral hepatitis, or tuberculosis. (Full text)

Clinical care of incarcerated people with HIV, viral hepatitis, or tuberculosis. The burden of HIV/AIDS and other transmissible diseases is higher in prison and jail settings than in the non-incarcerated communities that surround them. In this comprehensive review, we discuss available literature on the topic of clinical management of people infected with HIV, hepatitis B and C viruses, and tuberculosis in incarcerated settings in addition to co-occurrence of one or more of these infections

2016 Lancet PubMed

199. Global burden of HIV, viral hepatitis, and tuberculosis in prisoners and detainees. (PubMed)

Global burden of HIV, viral hepatitis, and tuberculosis in prisoners and detainees. The prison setting presents not only challenges, but also opportunities, for the prevention and treatment of HIV, viral hepatitis, and tuberculosis. We did a comprehensive literature search of data published between 2005 and 2015 to understand the global epidemiology of HIV, hepatitis C virus (HCV), hepatitis B virus (HBV), and tuberculosis in prisoners. We further modelled the contribution of imprisonment (...) and the potential impact of prevention interventions on HIV transmission in this population. Of the estimated 10·2 million people incarcerated worldwide on any given day in 2014, we estimated that 3·8% have HIV (389 000 living with HIV), 15·1% have HCV (1 546 500), 4·8% have chronic HBV (491 500), and 2·8% have active tuberculosis (286 000). The few studies on incidence suggest that intraprison transmission is generally low, except for large-scale outbreaks. Our model indicates that decreasing the incarceration

2016 Lancet

200. The perfect storm: incarceration and the high-risk environment perpetuating transmission of HIV, hepatitis C virus, and tuberculosis in Eastern Europe and Central Asia. (Full text)

The perfect storm: incarceration and the high-risk environment perpetuating transmission of HIV, hepatitis C virus, and tuberculosis in Eastern Europe and Central Asia. Despite global reductions in HIV incidence and mortality, the 15 UNAIDS-designated countries of Eastern Europe and Central Asia (EECA) that gained independence from the Soviet Union in 1991 constitute the only region where both continue to rise. HIV transmission in EECA is fuelled primarily by injection of opioids, with harsh (...) criminalisation of drug use that has resulted in extraordinarily high levels of incarceration. Consequently, people who inject drugs, including those with HIV, hepatitis C virus, and tuberculosis, are concentrated within prisons. Evidence-based primary and secondary prevention of HIV using opioid agonist therapies such as methadone and buprenorphine is available in prisons in only a handful of EECA countries (methadone or buprenorphine in five countries and needle and syringe programmes in three countries

2016 Lancet PubMed